drugset / Trial / NCT03063489

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

NCT03063489

Phase 1 Completed 15 enrolled Bausch Health Americas, Inc.
NaSingle-groupOpen-labelSupportive care

Summary

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of Loteprednol Etabonate Ophthalmic Gel, in Normal Healthy Volunteers

Timeline

Start
2015-02
Primary completion
2015-05
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Loteprednol Etabonate Other / unclassified 0.38 % Other

Indications